These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 3333732)

  • 21. Inter-individual variation in the mutagenic activation of 2-acetylaminofluorene by human liver in relation to animal metabolic models.
    Smith AJ; Chipman JK
    Mutagenesis; 1988 Jul; 3(4):323-8. PubMed ID: 3062320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolism and activation of 2-acetylaminofluorene in isolated rat hepatocytes.
    Dybing E; Søderlund E; Haug LT; Thorgeirsson SS
    Cancer Res; 1979 Aug; 39(8):3268-75. PubMed ID: 455309
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism and mutagenicity of aromatic amines by human fetal liver.
    Aune T; Haugen A; Dybing E
    Arch Toxicol; 1985 Jun; 57(2):136-8. PubMed ID: 4026573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of butylated hydroxytoluene-mediated modulation of 2-acetylaminofluorene mutagenicity in rat and human hepatocyte/Salmonella assays.
    Chipman JK; Davies JE; Paterson P
    Mutat Res; 1987 Mar; 187(3):105-12. PubMed ID: 3547109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic effect of diethylstilbestrol on the mutagenicity of 2-acetylaminofluorene and N-hydroxy-acetylaminofluorene in the Salmonella assay system.
    Allaben WT; Louie SC; Lazear EJ
    Cancer Lett; 1979 Jul; 7(2-3):109-14. PubMed ID: 476604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutagenic, cytotoxic, and teratogenic effects of 2-acetylaminofluorene and reactive metabolites in vitro.
    Faustman-Watts EM; Yang HY; Namkung MJ; Greenaway JC; Fantel AG; Juchau MR
    Teratog Carcinog Mutagen; 1984; 4(3):273-83. PubMed ID: 6147026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism and mutagenic activation of 2-acetylaminofluorene by human liver and lung.
    Boobis AR; Brodie MJ; McManus ME; Staiano N; Thorgeirsson SS; Davies DS
    Adv Exp Med Biol; 1981; 136 Pt B():1193-201. PubMed ID: 7046385
    [No Abstract]   [Full Text] [Related]  

  • 28. Activation of aromatic amines to mutagens by various animal species including man.
    Phillipson CE; Ioannides C
    Mutat Res; 1983 Dec; 124(3-4):325-36. PubMed ID: 6361543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhancement of the mutagenicity of carcinogenic arylamines by ethinyl estradiol.
    Purdy RH; Marshall MV
    Carcinogenesis; 1984 Dec; 5(12):1709-15. PubMed ID: 6499122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of N-acetoxy- and N-hydroxy-2-acetylaminofluorene to mutagenic and cytotoxic metabolites by V79 Chinese hamster cells.
    Glatt H; Oesch F
    Mutat Res; 1985 Apr; 149(2):265-9. PubMed ID: 3885026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Arylamine activation following chronic ethanol ingestion by rats: studies on the liver S9, microsomal and cytosolic fractions and comparison with Aroclor 1254 pretreatment.
    Traynor CA; Shane BS; Hajos AK; Winston GW
    Mutat Res; 1991 Mar; 247(1):153-66. PubMed ID: 2002800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of the hamster embryo cell transformation assay to detect metabolic activation of N-2-acetylaminofluorene by intact organ cells.
    Poiley JA; Ernst MK; Cavanaugh DM; Raineri R
    J Appl Toxicol; 1983 Dec; 3(6):326-31. PubMed ID: 6677656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influence of disulfiram on mutagenicity of the urinary metabolites of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene in the Salmonella test system.
    El-Torkey NM; Weisburger EK
    Mutat Res; 1983 Jul; 118(1-2):1-6. PubMed ID: 6346083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of 2-aminofluorene in the mutagenic activation of 2-acetylaminofluorene.
    Robertson IG
    Mutat Res; 1986 Nov; 175(3):153-7. PubMed ID: 3534560
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of promutagens by liver homogenates isolated from female mice at different ages; lack of significant differences.
    Guttenplan JB; Bliznakov EG
    Mech Ageing Dev; 1981 May; 16(1):29-35. PubMed ID: 6265715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interspecies homology of cytochrome P-450: toxicological significance of cytochrome P-450 cross-reactive with anti-rat P-448-H antibodies in liver microsomes from dogs, monkeys and humans.
    Ohta K; Kitada M; Ohi H; Komori M; Nagashima K; Sato N; Muroya K; Kodama T; Nagao M; Kamataki T
    Mutat Res; 1989 Jul; 226(3):163-7. PubMed ID: 2501680
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutagenicity and DNA damage induced by arylamines in the Salmonella/hepatocyte system.
    Staiano N; Erickson LC; Smith CL; Marsden E; Thorgeirsson SS
    Carcinogenesis; 1983; 4(2):161-7. PubMed ID: 6337737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Species differences in the metabolism of 2-acetylaminofluorene by hepatocytes in primary monolayer culture.
    Holme JA; Trygg B; Søderlund E
    Cancer Res; 1986 Apr; 46(4 Pt 1):1627-32. PubMed ID: 3948151
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of incubation and activation conditions on the hepatocyte-mediated plate incorporation and preincubation Salmonella typhimurium mutagenesis assays.
    Williams K; Inmon J; Lewtas J
    Teratog Carcinog Mutagen; 1983; 3(4):367-76. PubMed ID: 6138869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organ, species, and compound specificity in the metabolic activation of primary aromatic amines.
    Poupko JM; Radomski T; Santella RM; Radomski JL
    J Natl Cancer Inst; 1983 Jun; 70(6):1077-80. PubMed ID: 6574277
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.